Solcoseryl ( ophthalmic gel ) protects tissues from hypoxia or lack of nutrients. The drug is involved in the restoration of normal tissue functioning with reversible damage and promotes the healing of damage, while improving the quality of regeneration.
The active substance of the drug Solcoseryl (ophthalmic gel) is a standardized biologically and chemically dialysate, made from blood taken from healthy young calves. The component is obtained by separation and ultrafiltration. Thus, the active substance of the drug Solcoseryl (ophthalmic gel) does not contain a protein molecule, but contains many low molecular weight products that are derived from animal serum and blood cells. These components include amino acids, electrolytes, nucleosides, intermediate products of metabolism of fats and carbohydrates, oligopeptides and nucleotides.
The clinical effectiveness of the use of the drug is due to the synergism of all its components.
Solcoseryl (ophthalmic gel) refers to medications specially developed for the treatment of various lesions of the cornea, especially its stroma. This is due to the ability of the drug to reduce the risk of scar formation and activate regenerative processes.
The drug has a gel-like consistency, which is explained by the presence of carboxymethyl cellulose in its composition. The presence of sodium salt provides increased adhesive properties of the drug, which contributes to a uniform and long-lasting coating of the cornea. As a result of this, the active substance continuously penetrates into the affected tissue.
The drug Solcoseryl for the eyes is used for mechanical damage to the conjunctiva and cornea (with erosion or injury), to accelerate the healing of scars after surgical interventions. The medication is very effective for thermal, chemical burns (from exposure to alkalis and acids), radiation (from exposure to x-ray, ultraviolet and other types of short-wave radiation). The drug is indicated for corneal ulcers, keratitis (viral, bacterial or fungal etiology) during epithelialization in combination with antibiotics, antifungal and antiviral agents; with dystrophy of the cornea of various origins (including with lagophthalmic, neuroparalytic keratitis, “dry” keratoconjunctivitis, bullous keratopathy). The medication is used during the period of adaptation to soft or hard contact lenses to reduce its duration and improve tolerance.
According to the annotation, the recommended dosage of the drug is one drop up to four times per day. The attending physician may choose a different application regimen.
In severe cases, it is allowed (with the permission of the doctor) to use the gel every hour, one drop. When using other ophthalmic agents, the interval between instillations should be at least fifteen minutes.
When using the medication in the adaptation period with respect to hard lenses, the gel is applied directly to their surface before installation and after removal in the conjunctival sac.
When administering the drug, do not touch the tip of the tube with your fingers.
When adapting to soft lenses, Solcoseryl is applied in the evening after removing them.
After use, close the tube tightly.
As a rule, the drug is well tolerated by patients. After use, a slight burning sensation is possible, which is a short-term manifestation and is not considered a reason for refusing a medication.
During pregnancy and lactation before use, a doctor's consultation is necessary.
After using the drug for ophthalmic lesions, Solcoseryl gel reviews, for the most part, are positive. This is due to the wide spectrum of the drug and its relative availability. However, prior to use, it is necessary to familiarize yourself with the annotation to the drug.